Dr Priyanka Belawat
Over thirteen years of experience in venture and private equity investing in the healthcare space. Actively manages investments in bio-pharma, especially drug development in oncology, neurology, sepsis, fibrosis etc. in geographies like the US, Europe and selected emerging markets like China and India. Dr. Belawat holds a doctorate in molecular biology and genetics from the University of Zurich and a post-doc at HKUST. Board member of Neurelis Inc. (USA), Adrenomed AG (Germany), BioAtla (USA), iTeos (USA) and board observer to Sai Lifesciences (India).